🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT04378049
Active, not recruiting Not applicable

Robot-Assisted Partial Knee Replacement Versus Standard Total Knee Replacement

NCT04378049 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2020-11-23
Last updated
2025-05-09

Condition(s) studied

Knee Osteoarthritis

Investigational drug(s) / intervention(s)

Total knee arthroplastyRobot-assisted partial knee arthroplasty

Total knee arthroplasty: Surgeon will perform a total knee arthroplasty procedure according to local standard of care

Robot-assisted partial knee arthroplasty: Surgeon will perform a robot-assisted unicompartmental or bicompartmental knee arthroplasty procedure

Study summary

This is a pilot randomized trial to assess the feasibility of a definitive trial to determine the effect of robot-assisted partial knee replacements versus standard total knee replacements.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion criteria * Adult (18+) * Unicompartmental knee OA with or without concomitant patellofemoral OA, requiring surgical treatment * Two study surgeons independently agree that the patient is eligible for either treatment group Exclusion criteria * Inability to provide informed consent (e.g. cognitive disability, language barrier) * Revision knee surgery * Simultaneous bilateral knee surgery * Previous major knee surgery or trauma * The robot or required components are unavailable (e.g. technical difficulties, robot-specific disposables out of stock) * A CT scan cannot be obtained prior to surgery * Patient does not wish to participate

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
St. Joseph's Healthcare Hamilton Hamilton Ontario

More McMaster University trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04378049 on ClinicalTrials.gov ↗ ← All trials in Canada